Federal Circuit agrees with PTAB in optical patent appeal
The US Court of Appeals for the Federal Circuit has affirmed a decision by the US Patent Trial and Appeal Board which centered on the validity of a patent for an ophthalmic illuminator.
Inventor wins $1.2m from Medcomp and Martech over infringed catheter device
Sister medical device companies, Medical Components and Martech Medical Products, are liable for $1.2 million after a federal court in Pennsylvania ruled that both infringed a patent covering the design of a handle on a medical device.
US customs seize 100k fake N95s from Hong Kong
US customs officials at John F Kennedy International Airport in New York have seized 100,000 counterfeit 3M N95 masks imported from Hong Kong.
SCOTUS weighs future of assignor estoppel
The US Supreme Court will decide whether or not to maintain a legal doctrine which stops inventors who sell their patent rights from later claiming the patents are invalid.
Medline accuses competitor of confusing customers over COVID-19 PPE
A manufacturer of healthcare products including personal protective equipment has accused a newly incorporated company of trying to confuse consumers during the Covid-19 pandemic.
Boston Scientific and Nevro conclude patent dispute
Medical device company Nevro has agreed to drop a patent infringement suit which accused Boston Scientific of infringing patents related to spinal cord stimulation (SCS) therapy.
Haier division scores win in global patent dispute
Flexicare infringed a breathing tube patent owned by New Zealand appliance maker Fisher & Paykel (F&P), the English High Court has ruled.
Siemens drops heart catheter trade secret suit
A medical technology subsidiary of Siemens has settled a lawsuit against a former vice president, who it accused of stealing trade secrets related to heart catheter devices.
Philips defeats antitrust claims in ultrasound infringement suit
Philips was not anti-competitive when it refused a medical equipment maintenance company access to its software for ultrasound machines but did misuse its copyright, the US District Court for the Western District of Washington has ruled.
Fed Circuit affirms GSK $107m patent loss
The US Court of Appeals for the Federal Circuit rejected GlaxoSmithKline’s challenge of a $107 million verdict which found the drugmaker had infringed a dry-powder inhaler patent.